The research network is a well-established cloud-based collaboration forum that brings together a diverse group of hospitals, medical centers, biopharma companies, and CROs.
FREMONT, CA: Health Catalyst, a leading provider of data and analytics technology and services to healthcare organizations, has launched Health Catalyst Research Offering for biopharmaceutical companies, healthcare providers, and clinical research organizations (CROs). The new offering will help health systems safely convert and optimize their existing clinical databases, unlocking access to the mutually beneficial industry as well as research partnerships.
"For decades, clinical research has been heavily biased towards a finite number of leading urban medical centers, which tap into the same patient populations for clinical trial recruitment time and time again," stated Sadiqa Mahmood, DDS, MPH, General Manager and Senior Vice President, Life Sciences Business at Health Catalyst. "Unfortunately, the vast majority of citizens don't have an opportunity to participate, and a majority of clinical studies fail to enroll on time. Our new Health Catalyst Research Offering gets to the heart of these dual issues, using research-grade data as a way to connect more patients with clinical research opportunities."
The Health Catalyst Research Network and the Health Catalyst Touchstone Match are the two main components of the new offering. The research network is a well-established cloud-based collaboration forum that brings together a diverse group of hospitals, medical centers, biopharma companies, and CROs. Touchstone Match, an intelligent search function, and services that support data-informed research use cases – from clinical trial feasibility analyses to searches for patients eligible for real-world studies – make this ecosystem actionable.
The new Health Catalyst Research Offering, which uses existing real-world data such as electronic health records, enables health systems to proactively establish relationships with CROs and sponsors, creating opportunities for revenue enhancement and improved patient outcomes.